Aspirin

CHICAGO — Aspirin was not linked to a benefit in invasive disease-free survival, according to updated study results presented at ASCO Annual Meeting.

After left atrial appendage occlusion with a next-generation device, patients with atrial fibrillation had similar outcomes at 45 days regardless of medication regimen, researchers reported at TVT: The Structural Heart Summit.

ATLANTA — Clopidogrel monotherapy after 12 months of event free post-PCI dual antiplatelet therapy was associated with fewer MACCE and bleeding events vs. aspirin monotherapy in high bleeding risk patients, a speaker reported.

By inhibiting IL-4R alpha in aspirin-exacerbated respiratory disease, dupilumab improved respiratory symptoms and smell among other positive outcomes, according to a study published in The Journal of Allergy and Clinical Immunology.

Aspirin is the foundational treatment for secondary prevention of cardiac events and the standard therapy I have used for my patients for decades, but it can expose some patients to bleeding risk.

The U.S. Preventive Services Task Force has published a final recommendation that advises against the initiation of low-dose aspirin for primary CVD prevention in adults aged 60 years or older, a D-grade recommendation.

The benefits of ticagrelor and aspirin outweighed the risk for major hemorrhage in patients with mild to moderate ischemic stroke or at high risk for transient ischemic attack during 30 days of treatment, according to a Neurology study.

Effect of antiplatelet therapy on critically ill patients with COVID-19.

Eating at least two servings of avocado per week may lower the risk for CVD and coronary heart disease when compared with no avocado consumption, according to a recent study.

In patients requiring secondary CVD prevention, P2Y12 inhibitor monotherapy conferred reduced risk for major adverse CV events compared with aspirin monotherapy without raising risk for bleeding, researchers reported.